Researchers have hailed a breakthrough in the development of drugs to treat Alzheimer’s.Scientists have created a drug that ...

Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.

Find out all about the first two FDA drug approvals for the rare genetic disorder Niemann-Pick disease type C.

Absci Corporation's initiation of a phase 1 study using ABS-101 for the treatment of patients with IBD expected early 2025.

Lilly will add the center to a site in Lebanon, Indiana, where it is already spending about $9 billion to improve ...

The antibody-drug conjugate will be reviewed for the potential treatment of previously treated, unresectable or metastatic ...

Scientists from Harvard Medical School are using artificial intelligence (AI) to solve the problem of finding treatments for rare and neglected diseases. They have developed a new method, called ...

A UCL study found that lamotrigine is as effective as mexiletine for treating non-dystrophic myotonia, a rare muscle disorder ...

Rapamycin could counteract the harmful effects of Sodium Valproate, a common epilepsy medication, on fetal spinal cord development.

It took GLP-1 medications like Ozempic just seven years to surpass insulin as the the second most common treatment for type 2 ...

A doctor at a local cardiology practice was the first in the City of Mobile to perform a potentially less damaging treatment ...